News > High Point Clinical Trials Center's NASH webinar


High Point Clinical Trials Center's NASH webinar


 High Point Clinical Trials Center's webminar "Non-Alcoholic Steatohepatitis (NASH): intricacies of science, epidemiology, diagnosis and clinical research in the pathway towards approval of new treatments" will take place on October 11, 2017 at 2:00 pm EST.


This webminar will present key insight on the science and epidemiology of NASH, effective patient outreach, recruitment/screening initiatives as well as the development of novel biomarkers to overcome current diagnosis challenges associated with this disease.


In this webminar, Tim Montgomery, Manager, Technology and Commercial Development at OWL Metabolomics, together with Dr. Margarita Nunez (High Point CTC), Dr. Sabina Paglialunga (Celerion) and Dr. Michael Murphy (Pacific Biomarkers) will share important insight on how you and your development team can tackle NASH from study design through Proof of Concept.


Regisration here:

OWL is a trading name of
Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
+34 94 431 85 40

With this web OWL intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a
qualified physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 11/29/2021

With the collaboration of: